Page last updated: 2024-11-05

zolpidem and Atherosclerotic Parkinsonism

zolpidem has been researched along with Atherosclerotic Parkinsonism in 1 studies

Zolpidem: An imidazopyridine derivative and short-acting GABA-A receptor agonist that is used for the treatment of INSOMNIA.
zolpidem : An imidazo[1,2-a]pyridine compound having a 4-tolyl group at the 2-position, an N,N-dimethylcarbamoylmethyl group at the 3-position and a methyl substituent at the 6-position.

Research Excerpts

ExcerptRelevanceReference
"Zolpidem use might unmask preclinical Parkinson's disease, especially in patients with depression."3.81Risk of Parkinson's disease following zolpidem use: a retrospective, population-based cohort study. ( Huang, HC; Kao, CH; Lin, KH; Lu, MK; Muo, CH; Sung, FC; Tsai, CH, 2015)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Huang, HC1
Tsai, CH1
Muo, CH1
Lin, KH1
Lu, MK1
Sung, FC1
Kao, CH1

Other Studies

1 other study available for zolpidem and Atherosclerotic Parkinsonism

ArticleYear
Risk of Parkinson's disease following zolpidem use: a retrospective, population-based cohort study.
    The Journal of clinical psychiatry, 2015, Volume: 76, Issue:1

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Benzodiazepines; Comorbidity; Depression; Female; Humans

2015